Transcriptional regulation of miR-10a/b by TWIST-1 in myelodysplastic syndromes

Haematologica

Volumn 98, Issue 3, 2013, Pages 414-419

  Li, Xiang ^a,b   Xu, Feng ^a,c,d   Chang, Chunkang ^c,d   Byon, John ^e   Papayannopoulou, Thalia ^e   Deeg, H Joachim ^a,e   Marcondes, A Mario ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b JIANGNAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MICRORNA; MICRORNA 10A; MICRORNA 10B; PROTEIN P53; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG; MIRN10 MICRORNA, HUMAN; NUCLEAR PROTEIN; PROTEIN BINDING; TWIST1 PROTEIN, HUMAN;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LENTIVIRUS VECTOR; MALE; MYELODYSPLASTIC SYNDROME; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING; BONE MARROW; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADULT; AGED; APOPTOSIS; BONE MARROW; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NF-KAPPA B; NUCLEAR PROTEINS; PROTEIN BINDING; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; TWIST TRANSCRIPTION FACTOR; YOUNG ADULT;

EID: 84874509175     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2012.071753     Document Type: Article

References (25)

1. Corey SJ, Minden MD, Barber DL, Kantarjian H, Wang JC, Schimmer AD. Myelodysplastic syndromes: the complexity of stem-cell diseases (Review). Nat. Rev. Cancer. 2007;7(2):118-29.
2. Hussein K, Theophile K, Busche G, Schlegelberger B, Gohring G, Kreipe H, et al. Aberrant microRNA expression pattern in myelodysplastic bone marrow cells. Leuk Res. 2010;34(9):1169-74.
3. Dostalova MM, Krejcik Z, Votavova H, Belickova M, Vasikova A, Cermak J. Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome. European Journal of Human Genetics. 2011;19(3):313-9.
4. Vigna E, Recchia AG, Madeo A, Gentile M, Bossio S, Mazzone C, et al. Epigenetic regulation in myelodysplastic syndromes: implications for therapy. [Review]. Expert Opinion on Investigational Drugs. 2011; 20(4):465-93.
5. Sokol L, Caceres G, Volinia S, Alder H, Nuovo GJ, Liu CG, et al. Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes. Br J Haematol. 2011;153(1):24-32.
6. Pons A, Nomdedeu B, Navarro A, Gaya A, Gel B, Diaz T, et al. Hematopoiesis-related microRNA expression in myelodysplastic syndromes. Leuk Lymphoma. 2009; 50(11):1854-9.
7. Bartel DP. MicroRNAs: genomics, biogene-sis, mechanism, and function (Review). Cell. 2004;116(2):281-97.
8. Guo S, Lu J, Schlanger R, Zhang H, Wang JY, Fox MC, et al. MicroRNA miR-125a controls hematopoietic stem cell number. PNAS. 2010;107(32):14229-34.
9. Djuranovic S, Nahvi A, Green R. A parsi-monious model for gene regulation by miRNAs (Review). Science. 2011; 331(6017):550-3.
10. Koralov SB, Muljo SA, Galler GR, Krek A, Chakraborty T, Kanellopoulou C, et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell. 2008;132(5):860-74.
11. Li X, Marcondes AM, Gooley TA, Deeg HJ. The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes. Blood. 2010;116(13):2304-14.
12. Seal S, Hockenbery DM, Spaulding EY, Kiem H-P, Abbassi N, Deeg HJ. Differential responses of FLIP(long) and FLIP(short)-over-expressing human myeloid leukemia cells to TNF-αand TRAIL-initiated apoptotic signals. Exp Hematol. 2008;36(12):1660-72.
13. Tohyama K, Tohyama Y, Nakayama T, Ueda T, Nakamura T, Yoshida Y. A novel factor-dependent human myelodysplastic cell line, MDS92, contains haemopoietic cells of several lineages. Br J Haematol. 1995;91(4):795-9.
14. Marcondes AM, Li X, Gooley TA, Milless B, Deeg HJ. Identification of DJ-1/Park-7 as a determinant of stroma-dependent and TNFα-induced apoptosis in MDS by using mass spectrometry and phosphopeptide analysis. Blood. 2010;115(10):1993-2002.
15. Shiota M, Izumi H, Onitsuka T, Miyamoto N, Kashiwagi E, Kidani A, et al. Twist and p53 reciprocally regulate target genes via direct interaction. Oncogene. 2008; 27(42):5543-53.
16. Shiota M, Izumi H, Tanimoto A, Takahashi M, Miyamoto N, Kashiwagi E, et al. Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth. Cancer Res. 2009; 69(7):3148-56.
17. Liu Z, Zhu J, Cao H, Ren H, Fang X. miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer. Int J Oncol. 2012;40(5):1553-60.
18. Li X, Bryant E, Deeg HJ. Simultaneous demonstration of clonal chromosome abnormalities and apoptosis in individual marrow cells in myelodysplastic syndrome. Int J Hematol. 2004;80(2):140-5.
19. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer [Erratum appears in Nature. 2008 Sep 11;455(7210):256]. Nature. 2007; 449(7163):682-8.
20. Fang Y, Shi C, Manduchi E, Civelek M, Davies PF. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. PNAS. 2010;107(30):13450-5.
21. Ryan KM, Ernst MK, Rice NR, Vousden KH. Role of NF-kappaB in p53-mediated programmed cell death. Nature. 2000; 404(6780):892-7.
22. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ. TAK1 is a ubiquitindependent kinase of MKK and IKK. Nature. 2001;412(6844):346-51.
23. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson EG, et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol. 2010;28(4):341-7.
24. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes [Erratum appears in Blood 1998 Feb 1;91(3):1100]. Blood. 1997;89(6):2079-88.
25. Mhyre A, Marcondes AM, Spaulding EY, Deeg HJ. Stroma-dependent apoptosis in clonal hematopoietic precursors correlates with expression of PYCARD. Blood. 2009; 113(3):649-58.